Symptom clusters and sentinel symptoms in colorectal cancer patients during post-operative chemotherapy
-
By
-
Shengli Liu
-
Songyan Zhao
-
June 30, 2026
-
Clinical Scorecard: Identifying Symptom Patterns and Key Indicators in Colorectal Cancer Patients Undergoing Adjuvant Chemotherapy Post-Surgery
At a Glance
| Category | Detail |
|---|
| Condition | Colorectal Cancer |
| Key Mechanisms | Symptom clusters and their interrelatedness during chemotherapy |
| Target Population | Colorectal cancer patients undergoing post-operative adjuvant chemotherapy |
| Care Setting | Tertiary hospital |
Key Highlights
- Symptom burden increased from 8.32 symptoms at T1 to 13.3 at T3.
- Fatigue, decreased appetite, and disturbed sleep were the most prevalent symptoms.
- Symptom clusters evolved from three at T1 to four at T2 and T3.
- Seven sentinel symptoms identified across three time points.
- Significant increases in symptom severities over time.
Guideline-Based Recommendations
Diagnosis
- Utilize the M.D. Anderson Symptom Inventory-Gastrointestinal Cancer Module (MDASI-GI) for symptom assessment.
Management
- Implement targeted symptom management strategies based on identified sentinel symptoms.
Monitoring & Follow-up
- Monitor symptom severity and cluster evolution throughout chemotherapy cycles.
Risks
- Increased symptom burden may adversely affect treatment adherence and recovery.
Patient & Prescribing Data
220 colorectal cancer patients receiving first post-operative chemotherapy.
Cumulative increases in symptom burden necessitate proactive management.
Clinical Best Practices
- Employ holistic assessment strategies for symptom management.
- Recognize the interconnectedness of symptom clusters in treatment planning.
- Focus on both symptom severity and functional interference in patient evaluations.
Related Resources & Content
